Contribution By Saipriya Iyer
Chemomab Limited, a clinical-stage biopharmaceutical company, has recently announced the attainment of regulatory approvals for a clinical trial in Israel and the UK. These regulatory approvals have been granted to start the Phase 2 clinical study of
PHASE Scientific, a rapidly growing biotechnology firm, has reportedly announced that its innovative RNA extraction kit, PHASIFY™ VIRAL, has received CE (Conformité Européene) Mark approval, confirming that the product
Solar energy investments have displayed great resilience in the first half of 2020 against the economic slowdown due to the on-going COVID-19 pandemic. As per the latest news, Armenia has announced a tender for the development of a 55MW solar power p
Zoom, a communications technology company, has reportedly launched its 1st hardware product with a 27-inch screen, Zoom for Home, amid the COVID-19 crisis.
The product will considerably aid the rising number of people who are currently working from
Samsung Heavy Industries (SHI) is reportedly developing innovative methods to initiate smart shipping via extensive researches across research centers in Pangyo, Daeduk, & Geoje in Korea.
As per the statement made by the company, the recent focu
Tata Motors Limited, the Indian automotive giant, has reportedly announced the launch of Fleet Edge, an informed decision-making approach for the next phase of vehicle-based fleet management.
According to sources familiar with the knowledge of the m
Equillium, Inc. has recently announced that the clinical trial conducted by its partner, Biocon, has revealed itolizumab as a significant treatment option for COVID-19. In this clinical trial, itolizumab reportedly reduced the mortality rate among pa
Rigaku Corp. has reportedly announced the introduction of its new ZSX Primus IVi tube-below sequential WDXRF (wavelength dispersive X-ray fluorescence) spectrometer.
WDXRF analyzers, which are often used by research institutions in various applicati
UltraTech Cement Limited will reportedly sell the entire stake in its Chinese unit for a $120 million enterprise value, which is around ₹ 900 crore at current exchange rates.
According to the statement made in the recent stock-exchange filing